BlackRock Inc. - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 82 filers reported holding HOMOLOGY MEDICINES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$1,294,357
+32.1%
1,106,288
-0.1%
0.00%
Q2 2023$979,762
-21.0%
1,107,077
-8.0%
0.00%
Q1 2023$1,239,648
-24.8%
1,203,542
-8.0%
0.00%
Q4 2022$1,647,546
-37.4%
1,307,576
-20.0%
0.00%
Q3 2022$2,633,000
-19.3%
1,635,331
-1.3%
0.00%
Q2 2022$3,264,000
-72.3%
1,656,676
-57.2%
0.00%
Q1 2022$11,765,000
-9.9%
3,869,946
+7.9%
0.00%
Q4 2021$13,059,000
-52.2%
3,587,777
+3.4%
0.00%
-100.0%
Q3 2021$27,316,000
+11.9%
3,471,030
+3.4%
0.00%0.0%
Q2 2021$24,413,000
-9.4%
3,358,137
+17.2%
0.00%0.0%
Q1 2021$26,960,000
-13.6%
2,865,130
+3.7%
0.00%0.0%
Q4 2020$31,197,000
+6.4%
2,763,142
+0.8%
0.00%0.0%
Q3 2020$29,318,000
-31.3%
2,740,169
-2.5%
0.00%
-50.0%
Q2 2020$42,683,000
+30.4%
2,809,879
+33.4%
0.00%0.0%
Q1 2020$32,738,000
-26.5%
2,106,706
-2.1%
0.00%0.0%
Q4 2019$44,544,000
+15.0%
2,151,866
+0.5%
0.00%0.0%
Q3 2019$38,738,000
-5.0%
2,140,234
+2.7%
0.00%0.0%
Q2 2019$40,786,000
+4.9%
2,084,139
+48.7%
0.00%0.0%
Q1 2019$38,863,000
+19.0%
1,401,474
-4.0%
0.00%0.0%
Q4 2018$32,656,000
+129.2%
1,460,449
+134.3%
0.00%
+100.0%
Q3 2018$14,249,000
+31.6%
623,350
+17.4%
0.00%
Q2 2018$10,831,000530,9770.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q3 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders